156 related articles for article (PubMed ID: 16365030)
1. One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany.
Justenhoven C; Hamann U; Pierl CB; Rabstein S; Pesch B; Harth V; Baisch C; Vollmert C; Illig T; Brüning T; Ko Y; Brauch H
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):3015-8. PubMed ID: 16365030
[No Abstract] [Full Text] [Related]
2. Alcohol drinking and one-carbon metabolism-related gene polymorphisms on pancreatic cancer risk.
Suzuki T; Matsuo K; Sawaki A; Mizuno N; Hiraki A; Kawase T; Watanabe M; Nakamura T; Yamao K; Tajima K; Tanaka H
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2742-7. PubMed ID: 18843018
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk.
Lima CS; Ortega MM; Ozelo MC; Araujo RC; De Souza CA; Lorand-Metze I; Annichino-Bizzacchi JM; Costa FF
Leuk Res; 2008 Mar; 32(3):401-5. PubMed ID: 17655928
[TBL] [Abstract][Full Text] [Related]
4. One-carbon metabolism-related gene polymorphisms and risk of breast cancer.
Suzuki T; Matsuo K; Hirose K; Hiraki A; Kawase T; Watanabe M; Yamashita T; Iwata H; Tajima K
Carcinogenesis; 2008 Feb; 29(2):356-62. PubMed ID: 18174236
[TBL] [Abstract][Full Text] [Related]
5. One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan.
Matsuo K; Ito H; Wakai K; Hirose K; Saito T; Suzuki T; Kato T; Hirai T; Kanemitsu Y; Hamajima H; Tajima K
Carcinogenesis; 2005 Dec; 26(12):2164-71. PubMed ID: 16051637
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population.
Rouissi K; Ouerhani S; Oliveira E; Marrakchi R; Cherni L; Ben Othman F; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; Amorim A; Prata MJ; Benammar Elgaaied A
Cancer Genet Cytogenet; 2009 Nov; 195(1):43-53. PubMed ID: 19837268
[TBL] [Abstract][Full Text] [Related]
7. Influence of polymorphisms in MTHFR 677 C→T, TYMS 3R→2R and MTR 2756 A→G on NSCLC risk and response to platinum-based chemotherapy in advanced NSCLC.
Cui LH; Yu Z; Zhang TT; Shin MH; Kim HN; Choi JS
Pharmacogenomics; 2011 Jun; 12(6):797-808. PubMed ID: 21605004
[TBL] [Abstract][Full Text] [Related]
8. Methionine-dependence phenotype in the de novo pathway in BRCA1 and BRCA2 mutation carriers with and without breast cancer.
Beetstra S; Suthers G; Dhillon V; Salisbury C; Turner J; Altree M; McKinnon R; Fenech M
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2565-71. PubMed ID: 18842997
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in folate-related enzyme genes in idiopathic infertile Brazilian men.
Gava MM; Kayaki EA; Bianco B; Teles JS; Christofolini DM; Pompeo AC; Glina S; Barbosa CP
Reprod Sci; 2011 Dec; 18(12):1267-72. PubMed ID: 21775772
[TBL] [Abstract][Full Text] [Related]
10. Association between polymorphisms of folate-metabolizing enzymes and risk of prostate cancer.
Marchal C; Redondo M; Reyes-Engel A; Perea-Milla E; Gaitan MJ; Machuca J; Diaz F; Caballero J; Carnero J
Eur J Surg Oncol; 2008 Jul; 34(7):805-10. PubMed ID: 17967524
[TBL] [Abstract][Full Text] [Related]
11. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer.
Hekim N; Ergen A; Yaylim I; Yilmaz H; Zeybek U; Oztürk O; Isbir T
Cell Biochem Funct; 2007; 25(1):115-7. PubMed ID: 16134079
[TBL] [Abstract][Full Text] [Related]
12. Methylenetetrahydrofolate reductase and thymidylate synthase polymorphisms are not associated with breast cancer risk or phenotype.
Grieu F; Powell B; Beilby J; Iacopetta B
Anticancer Res; 2004; 24(5B):3215-9. PubMed ID: 15510613
[TBL] [Abstract][Full Text] [Related]
13. Interactions of 5'-UTR thymidylate synthase polymorphism with 677C → T methylene tetrahydrofolate reductase and 66A → G methyltetrahydrofolate homocysteine methyl-transferase reductase polymorphisms determine susceptibility to coronary artery disease.
Vijaya Lakshmi SV; Naushad SM; Rupasree Y; Seshagiri Rao D; Kutala VK
J Atheroscler Thromb; 2011; 18(1):56-64. PubMed ID: 20962453
[TBL] [Abstract][Full Text] [Related]
14. Association of maternal polymorphisms in folate metabolizing genes with chromosome damage and risk of Down syndrome offspring.
Coppedè F; Migheli F; Bargagna S; Siciliano G; Antonucci I; Stuppia L; Palka G; Migliore L
Neurosci Lett; 2009 Jan; 449(1):15-9. PubMed ID: 18983896
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses.
Lissowska J; Gaudet MM; Brinton LA; Chanock SJ; Peplonska B; Welch R; Zatonski W; Szeszenia-Dabrowska N; Park S; Sherman M; Garcia-Closas M
Int J Cancer; 2007 Jun; 120(12):2696-703. PubMed ID: 17311260
[TBL] [Abstract][Full Text] [Related]
16. MTR polymorphic variant A2756G and retinoblastoma risk in Brazilian children.
de Lima EL; da Silva VC; da Silva HD; Bezerra AM; de Morais VL; de Morais AL; Cruz RV; Barros MH; Hassan R; de Freitas AC; Muniz MT
Pediatr Blood Cancer; 2010 Jul; 54(7):904-8. PubMed ID: 20310006
[TBL] [Abstract][Full Text] [Related]
17. Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women.
Barbosa PR; Stabler SP; Machado AL; Braga RC; Hirata RD; Hirata MH; Sampaio-Neto LF; Allen RH; Guerra-Shinohara EM
Eur J Clin Nutr; 2008 Aug; 62(8):1010-21. PubMed ID: 17522601
[TBL] [Abstract][Full Text] [Related]
18. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in human breast cancer.
Li SY; Rong M; Iacopetta B
Oncol Rep; 2006 Jan; 15(1):221-5. PubMed ID: 16328059
[TBL] [Abstract][Full Text] [Related]
19. Alcohol consumption and genetic variation in methylenetetrahydrofolate reductase and 5-methyltetrahydrofolate-homocysteine methyltransferase in relation to breast cancer risk.
Platek ME; Shields PG; Marian C; McCann SE; Bonner MR; Nie J; Ambrosone CB; Millen AE; Ochs-Balcom HM; Quick SK; Trevisan M; Russell M; Nochajski TH; Edge SB; Freudenheim JL
Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2453-9. PubMed ID: 19706843
[TBL] [Abstract][Full Text] [Related]
20. Methyl group metabolism gene polymorphisms as modifier of breast cancer risk in Italian BRCA1/2 carriers.
Pepe C; Guidugli L; Sensi E; Aretini P; D'Andrea E; Montagna M; Manoukian S; Ottini L; Radice P; Viel A; Bevilacqua G; Caligo MA
Breast Cancer Res Treat; 2007 May; 103(1):29-36. PubMed ID: 17151928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
